161 related articles for article (PubMed ID: 7030959)
1. Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model.
Durham DL; Mattingly SJ; Doran TI; Milligan TW; Straus DC
Infect Immun; 1981 Nov; 34(2):448-54. PubMed ID: 7030959
[TBL] [Abstract][Full Text] [Related]
2. Protease production by clinical isolates of type III group B streptococci.
Straus DC; Mattingly SJ; Milligan TW; Doran TI; Nealon TJ
J Clin Microbiol; 1980 Sep; 12(3):421-3. PubMed ID: 7012176
[TBL] [Abstract][Full Text] [Related]
3. Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci.
Yeung MK; Mattingly SJ
Infect Immun; 1984 May; 44(2):217-21. PubMed ID: 6370860
[TBL] [Abstract][Full Text] [Related]
4. Group B streptococci: extracellular neuraminidase production and virulence in mouse.
Orefici G; De Stasio A; Guarino M; Martini A; Orsi N
Microbiologica; 1984 Jan; 7(1):75-8. PubMed ID: 6374384
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of type III group B streptococcal mutants defective in biosynthesis of the type-specific antigen.
Yeung MK; Mattingly SJ
Infect Immun; 1983 Oct; 42(1):141-51. PubMed ID: 6352490
[TBL] [Abstract][Full Text] [Related]
6. Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease.
Musser JM; Mattingly SJ; Quentin R; Goudeau A; Selander RK
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4731-5. PubMed ID: 2660146
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the virulence factors of group B streptococci: correlation with sialic acid content.
Shigeoka AO; Rote NS; Santos JI; Hill HR
J Infect Dis; 1983 May; 147(5):857-63. PubMed ID: 6341485
[TBL] [Abstract][Full Text] [Related]
8. Extracellular neuraminidase production by clinical isolates of group B streptococci from infected neonates.
Mattingly SJ; Milligan TW; Pierpont AA; Straus DC
J Clin Microbiol; 1980 Oct; 12(4):633-5. PubMed ID: 6999031
[TBL] [Abstract][Full Text] [Related]
9. Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci.
Milligan TW; Baker CJ; Straus DC; Mattingly SJ
Infect Immun; 1978 Sep; 21(3):738-46. PubMed ID: 361576
[TBL] [Abstract][Full Text] [Related]
10. Lethal synergism induced in mice by influenza type A virus and type Ia group B streptococci.
Jones WT; Menna JH; Wennerstrom DE
Infect Immun; 1983 Aug; 41(2):618-23. PubMed ID: 6347892
[TBL] [Abstract][Full Text] [Related]
11. Density profile of group B streptococci, type III, and its possible relation to enhanced virulence.
Håkansson S; Holm SE; Wagner M
J Clin Microbiol; 1987 Apr; 25(4):714-8. PubMed ID: 3106411
[TBL] [Abstract][Full Text] [Related]
12. Adult mice as a model for early onset group B streptococcal disease.
Wennerstrom DE; Schutt RW
Infect Immun; 1978 Feb; 19(2):741-4. PubMed ID: 344223
[TBL] [Abstract][Full Text] [Related]
13. Type-specific capsular antigen is associated with virulence in late-onset group B Streptococcal type III disease.
Klegerman ME; Boyer KM; Papierniak CK; Levine L; Gotoff SP
Infect Immun; 1984 Apr; 44(1):124-9. PubMed ID: 6423540
[TBL] [Abstract][Full Text] [Related]
14. Glutathione Synthesis Contributes to Virulence of
Walker EA; Port GC; Caparon MG; Janowiak BE
J Bacteriol; 2019 Oct; 201(20):. PubMed ID: 31331978
[No Abstract] [Full Text] [Related]
15. Factors influencing release of type III antigens by group B streptococci.
Doran TI; Straus DC; Mattingly SJ
Infect Immun; 1981 Feb; 31(2):615-23. PubMed ID: 7012015
[TBL] [Abstract][Full Text] [Related]
16. In vitro method to differentiate isolates of type III Streptococcus agalactiae from symptomatic and asymptomatic patients.
Maurer JJ; Mattingly SJ
J Clin Microbiol; 1988 Apr; 26(4):686-91. PubMed ID: 3284898
[TBL] [Abstract][Full Text] [Related]
17. A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae.
Seifert KN; Adderson EE; Whiting AA; Bohnsack JF; Crowley PJ; Brady LJ
Microbiology (Reading); 2006 Apr; 152(Pt 4):1029-1040. PubMed ID: 16549667
[TBL] [Abstract][Full Text] [Related]
18. Mouse protection test for group B Streptococcus type III.
Baltimore RS; Kasper DL; Vecchitto J
J Infect Dis; 1979 Jul; 140(1):81-8. PubMed ID: 88492
[TBL] [Abstract][Full Text] [Related]
19. Group B streptococcal C protein-associated antigens: association with neonatal sepsis.
Chun CS; Brady LJ; Boyle MD; Dillon HC; Ayoub EM
J Infect Dis; 1991 Apr; 163(4):786-91. PubMed ID: 2010631
[TBL] [Abstract][Full Text] [Related]
20. Virulence of strains of new types and type candidates of group B streptococci (Streptococcus agalactiae). Comparative evaluation using mice and a chicken embryo model.
Wagner M; Kaatz M
Adv Exp Med Biol; 1997; 418():819-21. PubMed ID: 9331778
[No Abstract] [Full Text] [Related]
[Next] [New Search]
